pipette
ENEnglish

A multi-scale cell-type resolved map of trans-regulatory architecture in the aging human brain

X. Cao, Y. Wang, H. Sun, R. Feng, H. Zhang, Y. Li, H. Lee, B. Karaahmet, B. Li, C. Gersbach, G. E. Crawford, M. Taga, M. S. Beeri, A. S. Buchman, H.-U. Klein, P. De Jager, D. A. Bennett, The Alzheimer's Disease Functional Genomics Consortium, G. Wang, K. K. Dey

Preprint

En palabras de los autores

Mapping genetic effects on distal genes and regulatory programs is essential for understanding how genetic variation influences complex diseases; yet trans-QTL discovery remains limited by weak effect sizes, extensive multiple testing and poor reproducibility. Here, we introduce TransMap, a generalizable computational framework that combines multi-scale trans-QTL mapping with multi-phenotype genetic colocalization to improve the discovery and interpretation of distal regulatory variants. Beyond individual trans-eGenes, TransMap constructs local co-regulatory program phenotypes that account for background expression variation to improve the detection of weak, coordinated distal genetic effects. Across a broad range of simulation settings, TransMap achieved 9.2-36.7% higher trans-QTL discovery power than existing methods while maintaining well-controlled type I error rates. We applied TransMap to bulk and single-nucleus transcriptomic profiles from the aging human brain in the ADSP Functional Genomics Consortium (FunGen-AD), further integrating proteomic, glycoproteomic and metabolomic biomarker measurements (average N=476 donors). Genome-wide fine-mapping of TransMap single-gene and program-level QTL yielded variant annotations with 2.75-2.88x heritability enrichment across 57 complex diseases and traits (average N=307K), with complementary heritability information captured across regulatory scales. Multi-phenotype colocalization identified 49,532 trans-regulatory events supported by shared genetic signals with cis-eQTL or biomarker-QTL, including 1,825 candidate cis-trans-biomarker regulatory configurations. TransMap further revealed an asymmetric cross-cell-type regulatory architecture in which neuronal cis-regulatory signals preferentially associate with coordinated glial trans-regulatory responses, supported by co-culture experiments and spatial transcriptomics. Alzheimer's disease (AD) GWAS-prioritized colocalization identified trans-regulatory associations in 115 AD-associated loci, including a KNOP1 cis-eQTL associated in trans with a microglial regulatory program containing MS4A4E, with additional support from statistical mediation analysis. TransMap provides a multi-scale, cell-type-resolved atlas of trans-regulatory variation and a generalizable framework for elucidating the regulatory architecture of complex diseases.

Resultado principalEl resumen no menciona limitaciones.

En palabras simples Resumen con IA

Los autores crearon TransMap, una nueva herramienta computacional que encuentra variantes genéticas distantes que afectan la regulación de genes. TransMap detecta efectos coordinados débiles al agrupar genes en programas de co-regulación locales. En simulaciones, TransMap encontró 9.2-36.7% más variantes regulatorias distantes que los métodos existentes. Aplicado a datos de cerebro humano envejecido de 476 donantes, la herramienta reveló 49,532 eventos regulatorios distantes. El estudio encontró que las señales neuronales desencadenan preferentemente respuestas coordinadas en células gliales.

Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale.

Apareció: lunes, 9 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.05.26367384